An overview of cancer drugs approved through expedited approval programs and orphan medicine designation globally between 2011 and 2020.

Saved in:
Bibliographic Details
Title: An overview of cancer drugs approved through expedited approval programs and orphan medicine designation globally between 2011 and 2020.
Authors: Wang S; National Central Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China., Yang Q; The Whiteoak Group, Inc., Rockville, MD, USA., Deng L; The Whiteoak Group, Inc., Rockville, MD, USA., Lei Q; National Central Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China., Yang Y; Guizhou Provincial People's Hospital, Guiyang, China., Ma P; National Central Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China., Men Y; The Whiteoak Group, Inc., Rockville, MD, USA., Yung BC; The Whiteoak Group, Inc., Rockville, MD, USA., Lee RJ; Division of Pharmaceutics and Pharmacology, The Ohio State University, Columbus, OH, USA., Zhang M; The Whiteoak Group, Inc., Rockville, MD, USA., Li N; National Central Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. Electronic address: Lining@cicams.ac.cn.
Source: Drug discovery today [Drug Discov Today] 2022 May; Vol. 27 (5), pp. 1236-1250. Date of Electronic Publication: 2021 Dec 29.
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9604391 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-5832 (Electronic) Linking ISSN: 13596446 NLM ISO Abbreviation: Drug Discov Today Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1878-5832
DOI:10.1016/j.drudis.2021.12.021